Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-23

FDA Approved: TEMOZOLOMIDE — Original Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved temozolomide from Nivagen Pharmaceuticals under an original application for the treatment of malignant gliomas, including glioblastoma multiforme a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temozolomide (Temozolomide)

Snippet

ORIG AP for TEMOZOLOMIDE (TEMOZOLOMIDE)